Job title: Senior Research Fellow
Tariq Ghayur received his Ph.D (1987) in Immunology from the Department of Physiology, McGill University, Montreal, Canada and did his post-doctoral training at McGill (1987-’88) and Dana Farber Cancer Institute (1988-’90). He joined AbbVie Inc. in 1990. Tariq has worked on both small molecule and therapeutic antibody discovery programs. From 1998-2004 he led two therapeutic antibody discovery project teams and delivered 2 drug development candidates; from 2005 – 2009 he led the dual variable domain Ig (DVD – Ig™) Initiative and; from 2010 – 2016 Tariq established & led the Novel Biologics group at AbbVie. Currently, he leads the Foundational Immunology Department. Tariq holds several patents and is the author of many peer-reviewed scientific publications. In addition to therapeutic antibodies and antibody generation technologies, his areas of interest are antibody engineering, inflammation, lymphocyte and antigen presenting cell biology, cytokine biology and transplantation rejection.